SavedAdd your journal

Journals / The Anatolian Journal of Cardiology / 2019 / Cilt: 21 - Sayı: 1

The role of rivaroxaban in left ventricular thrombi

Mahmoud ABDELNABY
Abdallah ALMAGHRABY
Ola ABDELKARİM
Yehia SALEH
Basma HAMMAD
Haitham BADRAN
Pages
47–50
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ABDELNABY, M., ALMAGHRABY, A., ABDELKARİM, O., SALEH, Y., HAMMAD, B., BADRAN, H. (2019). The role of rivaroxaban in left ventricular thrombi. The Anatolian Journal of Cardiology, Cilt: 21 - Sayı: 1, 47–50. https://ajindex.com/articles/365238

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Weinsaft JW, Kim J, Medicherla CB, Ma CL, Codella NC, Kukar N, et al. Echocardiographic algorithm for post–myocardial infarction LV thrombus: a gatekeeper for thrombus evaluation by delayed enhancement CMR. JACC Cardiovasc Imaging 2016; 9: 505-15
  2. Cregler LL. Antithrombotic therapy in left ventricular thrombosis and systemic embolism. Am Heart J 1992; 123: 1110-4
  3. Udell JA, Wang JT, Gladstone DJ, Tu JV. Anticoagulation after anterior myocardial infarction and the risk of stroke. PLoS One 2010; 5: e12150
  4. Makrides CA. Resolution of left ventricular postinfarction thrombi in patients undergoing percutaneous coronary intervention using rivaroxaban in addition to dual antiplatelet therapy. BMJ Case Rep 2016; 2016
  5. Seecheran R, Seecheran V, Persad S, Seecheran NA. Rivaroxaban as an antithrombotic agent in a patient with ST-segment elevation myocardial infarction and left ventricular thrombus: a case report. J Investig Med High Impact Case Rep 2017; 5: 2324709617697991
  6. Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 2013; 15: 625-51
  7. Saar JA, Maack C; European Society of Cardiology. Diagnosis and management of acute pulmonary embolism. ESC guidelines 2014. Herz 2015; 40: 1048-54
  8. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al.; ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37: 2893-962
  9. Yildirim E, Kalkan K, Ipek E, Demirelli S, Ermiş E. Successful resolution of left ventricular thrombus with apixaban treatment. International Journal of the Cardiovascular Academy 2016; 2: 57-8
  10. Kaku B. Intra-cardiac thrombus resolution after anti-coagulation therapy with dabigatran in a patient with mid-ventricular obstructive hypertrophic cardiomyopathy: a case report. J Med Case Rep 2013; 7: 238
  11. Nagamoto Y, Shiomi T, Matsuura T, Okahara A, Takegami K, Mine D, et al. Resolution of a left ventricular thrombus by the thrombolytic action of dabigatran. Heart Vessels 2014; 29: 560-2
  12. Yamamoto T, Konishi T, Funayama N, Kikuchi B, Hotta D, Ohori K. Resolution of Left Ventricular Thrombus after Dabigatran Therapy in Two Patients with Old Anteroseptal Myocardial Infarction. Cardiol Pharmacol 2015; 4: 152
  13. Las Casas Jr AA, Las Casas AA, Borges MAF, M